Deploying vibration-controlled transient elastography/controlled attenuation parameter devices at the population level is a financially advantageous solution to address the epidemic of fatty liver disease.
Scott C. Howell, DO
Advertisement
Articles by Scott C. Howell, DO
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Tozorakimab Cuts COPD Exacerbations Up to 34% in Phase 3 Trials
2
Bringing CAR T-Cell Therapy Into Community Cancer Centers
3
The True Cost of Running a Community CAR T-Cell Program
4
Trump Admin Awards $106M to Expand Rural Health Care in NY, RI, MI
5